Baird Medical Investment Holdings (BDMD) Finished Goods (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has reported Finished Goods for 3 consecutive years, with $511000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Finished Goods fell 28.76% year-over-year to $511000.0 in Q4 2025; TTM through Dec 2025 was $511000.0, a 28.76% decrease from a year earlier, with the FY2025 full-year figure at $511000.0, down 28.76% from the prior year.
• Finished Goods was $511000.0 for Q4 2025 at Baird Medical Investment Holdings, down from $742279.0 in the prior quarter.
• Over five years, Finished Goods peaked at $742279.0 in Q2 2025 and troughed at $312871.0 in Q4 2023.
• A 3-year average of $570865.5 and a median of $614156.0 in 2024 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods soared 129.27% in 2024 and slipped 28.76% in 2025, its largest moves.
• Over 3 years, Finished Goods stood at $312871.0 in 2023, then soared by 129.27% to $717312.0 in 2024, then dropped by 28.76% to $511000.0 in 2025.
• The last three Finished Goods figures came in at $511000.0 (Q4 2025), $742279.0 (Q2 2025), and $717312.0 (Q4 2024), per Business Quant data.